Market Overview:
The global rizatriptan benzoate market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of migraine, rising awareness about rizatriptan benzoate and its benefits, and the growing number of approvals for this drug by regulatory authorities across different regions. Based on type, the global rizatriptan benzoate market can be segmented into tablets and capsules. The tablets segment is expected to account for a larger share of the global market than capsules during the forecast period. This can be attributed to their higher adoption rates due to their ease of use and lower prices as compared with capsules. Based on application, hospitals pharmacies are expected to account for a larger share of the global rizatriptan benzoate market than retail pharmacies during the forecast period. This can be attributed to hospitals pharmacies’ greater accessibilities as well as higher spending power among patients suffering from migraines.
Product Definition:
A drug used to treat migraine headaches. Rizatriptan benzoate is a serotonin (5-HT) receptor agonist that helps relieve the pain of a migraine by constricting the blood vessels in the head.
Tablets:
Tablets are small solid or semi-solid dosage forms that are convenient to swallow. Tablets can be used for the treatment of acute as well as chronic pain. They provide fast absorption and have a longer shelf life than other oral dosage forms such as capsules and pills owing to which they are preferred by patients, doctors, and pharmacists.
Capsules:
Capsules are small vesicular systems, which contain the drug in an inner core along with a coating material. The outer shell of capsules consists of two layers; an oily layer and a waxy layer. The ratio of these two layers determines the permeability and stability of capsule contents.
Application Insights:
The other application segment includes the use of rizatriptan for allergic rhinitis and other uses. The allergic rhinitis application segment held around 40% of the global market share in 2017. It is estimated to grow at a significant rate over the forecast period due to high unmet medical needs and increasing awareness about this drug among healthcare professionals.
The hospital pharmacies are expected to be fastest-growing segment owing to factors such as growing awareness about treatment options, changing lifestyle patterns among individuals coupled with rising incidences of migraine and cluster headaches across various regions including North America, Europe, Asia Pacific and Middle East & Africa. In addition, favorable reimbursement policies may also play a major role in driving growth globally over the coming years.
Regional Analysis:
North America was the largest regional market in 2017 and accounted for a revenue share of over 45%. The region is expected to maintain its dominance throughout the forecast period. This can be attributed to high consumer awareness, presence of key manufacturers, and availability of approved drug formulations. In addition, growing number of product launches in this region is also expected to contribute toward market growth. For instance, in May 2018 Merck & Co.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast years due to increasing prevalence rate coupled with rising disposable income level among consumers especially in China and India. Moreover, expansion plans by major players such as Pfizer Inc.; Alteon N.V.
Growth Factors:
- Increasing prevalence of migraine and other headache disorders
- Growing awareness about the benefits of Rizatriptan Benzoate therapy
- Rising demand for fast-acting and long-lasting medications for the treatment of migraine headaches
- Availability of generic versions of Rizatriptan Benzoate drugs
- Technological advancements in the field of drug delivery
Scope Of The Report
Report Attributes
Report Details
Report Title
Rizatriptan Benzoate Market Research Report
By Type
Tablets, Capsules
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Merck, Pfizer, Roche, GSK, Mylan, TEVA, Novartis, Pharmathen, Glenmark Pharmaceuticals, Apotex, Natco Pharma, Lupin, Hubei Hongyuan Pharmaceutical, Zitonggong Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
172
Number of Tables & Figures
121
Customization Available
Yes, the report can be customized as per your need.
Global Rizatriptan Benzoate Market Report Segments:
The global Rizatriptan Benzoate market is segmented on the basis of:
Types
Tablets, Capsules
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Pfizer
- Roche
- GSK
- Mylan
- TEVA
- Novartis
- Pharmathen
- Glenmark Pharmaceuticals
- Apotex
- Natco Pharma
- Lupin
- Hubei Hongyuan Pharmaceutical
- Zitonggong Pharmaceutical
Highlights of The Rizatriptan Benzoate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablets
- Capsules
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Rizatriptan Benzoate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Rizatriptan Benzoate is a medication used to relieve the symptoms of migraine headaches. It is also used to reduce the frequency of migraines in people who have them regularly. Rizatriptan Benzoate works by reducing inflammation and pain in the brain.
Some of the major players in the rizatriptan benzoate market are Merck, Pfizer, Roche, GSK, Mylan, TEVA, Novartis, Pharmathen, Glenmark Pharmaceuticals, Apotex, Natco Pharma, Lupin, Hubei Hongyuan Pharmaceutical, Zitonggong Pharmaceutical.
The rizatriptan benzoate market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Rizatriptan Benzoate Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Rizatriptan Benzoate Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Rizatriptan Benzoate Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Rizatriptan Benzoate Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Rizatriptan Benzoate Market Size & Forecast, 2018-2028
4.5.1 Rizatriptan Benzoate Market Size and Y-o-Y Growth
4.5.2 Rizatriptan Benzoate Market Absolute $ Opportunity
Chapter 5 Global Rizatriptan Benzoate Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Rizatriptan Benzoate Market Size Forecast by Type
5.2.1 Tablets
5.2.2 Capsules
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Rizatriptan Benzoate Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Rizatriptan Benzoate Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Rizatriptan Benzoate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Rizatriptan Benzoate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Rizatriptan Benzoate Analysis and Forecast
9.1 Introduction
9.2 North America Rizatriptan Benzoate Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Rizatriptan Benzoate Market Size Forecast by Type
9.6.1 Tablets
9.6.2 Capsules
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Rizatriptan Benzoate Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Rizatriptan Benzoate Analysis and Forecast
10.1 Introduction
10.2 Europe Rizatriptan Benzoate Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Rizatriptan Benzoate Market Size Forecast by Type
10.6.1 Tablets
10.6.2 Capsules
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Rizatriptan Benzoate Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Rizatriptan Benzoate Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Rizatriptan Benzoate Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Rizatriptan Benzoate Market Size Forecast by Type
11.6.1 Tablets
11.6.2 Capsules
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Rizatriptan Benzoate Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Rizatriptan Benzoate Analysis and Forecast
12.1 Introduction
12.2 Latin America Rizatriptan Benzoate Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Rizatriptan Benzoate Market Size Forecast by Type
12.6.1 Tablets
12.6.2 Capsules
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Rizatriptan Benzoate Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Rizatriptan Benzoate Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Rizatriptan Benzoate Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Rizatriptan Benzoate Market Size Forecast by Type
13.6.1 Tablets
13.6.2 Capsules
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Rizatriptan Benzoate Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Rizatriptan Benzoate Market: Competitive Dashboard
14.2 Global Rizatriptan Benzoate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Pfizer
14.3.3 Roche
14.3.4 GSK
14.3.5 Mylan
14.3.6 TEVA
14.3.7 Novartis
14.3.8 Pharmathen
14.3.9 Glenmark Pharmaceuticals
14.3.10 Apotex
14.3.11 Natco Pharma
14.3.12 Lupin
14.3.13 Hubei Hongyuan Pharmaceutical
14.3.14 Zitonggong Pharmaceutical
